8 studies found for:    Open Studies | "Rhabdomyolysis"
Show Display Options
Rank Status Study
1 Recruiting Plasma Neutrophil Gelatinase Associated Lipocalin Levels During Emergency Management of Rhabdomyolysis
Conditions: Rhabdomyolysis;   Acute Kidney Failure
Intervention: Biological: Plasma NGAL level
2 Unknown  Study of the Causes of the Breakdown of Muscle Fibers in Hospitalized Patients
Conditions: Rhabdomyolysis;   Myopathy;   Acute Renal Failure;   Neuroleptic Malignant Syndrome
Intervention:
3 Recruiting Extracorporeal Therapy for the Removal of Myoglobin Using the CytoSorb in Patients With Rhabdomyolysis
Condition: Rhabdomyolysis
Interventions: Device: CytoSorb Device;   Procedure: CVVH
4 Recruiting Myoglobin Removal by High Cut-off CVVHD
Conditions: Rhabdomyolysis;   Renal Failure
Interventions: Device: septeX;   Device: HF CVVH
5 Recruiting Neuroprotection With Statin Therapy for Acute Recovery Trial Phase 2
Conditions: Stroke;   Rhabdomyolysis;   Jaundice
Interventions: Drug: Lovastatin;   Other: Placebo
6 Recruiting Nutritional Prevention of Exertional Muscle Dysfunction
Conditions: Muscle Dysfunction;   Exertional Rhabdomyolysis;   Muscle Strength
Interventions: Dietary Supplement: Choline;   Dietary Supplement: Placebo
7 Unknown  The Association of Genetic Polymorphisms With Statin-Induced Myopathy.
Conditions: Rhabdomyolysis;   Myopathy
Intervention: Genetic: DNA
8 Available Compassionate Use of Triheptanoin (C7) for Fatty Acid Oxidation Disorders and Glycogen Storage Disease
Conditions: Very Long-chain acylCoA Dehydrogenase (VLCAD) Deficiency;   Carnitine Palmitoyltransferase Deficiencies (CPT1, CPT2);   Mitochondrial Trifunctional Protein Deficiency;   Long-chain Hydroxyacyl-CoA Dehydrogenase Deficiency;   Glycogen Storage Disorders;   Pyruvate Carboxylase Deficiency, Type B;   Acyl-coA Dehydrogenase, Type 9
Intervention: Drug: triheptanoin

Indicates status has not been verified in more than two years